Brandon Kotaniemi

Brandon Kotaniemi currently serves as SVP, Head of Commercial at Mural Oncology since October 2024. Prior to this role, Brandon held positions including Senior Vice President - ImmunoOncology Commercial Franchise Head at Coherus BioSciences from August 2021 to May 2024, and Head of Portfolio Marketing Strategy (ex-China) at BeiGene from May 2019 to August 2021. Additional experience includes leadership roles at Pharmacyclics (AbbVie), Pfizer, Medivation, Gilead Sciences, Genentech, and AstraZeneca, spanning various aspects of oncology marketing and commercial strategy. Brandon's educational background includes degrees from Stanford University Graduate School of Business, The University of Chicago Booth School of Business, University of Oregon, and studies at Universidad de las Américas Puebla.